2-Bromo-4-oxo-4,5-dihydrothieno[3,2-c]pyridine-7-carbonitrile

Catalog No.: 
ACTGHB955
CAS No.: 
55040-43-2
Molecular Formula: 
C8H3BrN2OS
Molecular Weight: 
255.10
2-Bromo-4-oxo-4,5-dihydrothieno[3,2-c]pyridine-7-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$735.00InquiryInquiry
5g95%$2202.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Bromo-4-oxo-4,5-dihydrothieno[3,2-c]pyridine-7-carbonitrile
IUPAC Name2-bromo-4-oxo-4,5-dihydrothieno[3,2-c]pyridine-7-carbonitrile
MDL No.MFCD14706286
Molecular FormulaC8H3BrN2OS
Molecular Weight255.10
SMILESN#CC1=CNC(C2=C1SC(Br)=C2)=O
InChI KeyFIAFOJCIZMGXIV-UHFFFAOYSA-N
Synonym2-broMo-4-hydroxythieno[3,2-c]pyridine-7-carbonitrile;2-broMo-4-oxo-4,5-dihydrothieno[3,2-c]pyridine-7-carbonitrile;2-BroMo-7-cyano-5H-thieno[3,2-c]pyridin-4-one;2-bromo-4,5-dihydro-4-oxo-Thieno[3,2-c]pyridine-7-carbonitrile;Thieno[3,2-c]pyridine-7-carbonitrile, 2-bromo-4,5-dihydro-4-oxo-;2-Bromo-7-cyano-4-oxo-5-aza-4,5-dihydrobenz-othiophene
CAS No.55040-43-2

Synthetic Route by SureRoute

1. ACTGHB955 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDTRG207 route compound structure diagram
    ACDTRG20755040-34-1In Stock
  2. Then
  3. ACTGHB955 route product structure diagram
    ACTGHB95555040-43-2
Inquiry

2. ACTGHB955 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDTRG207 route compound structure diagram
    ACDTRG20755040-34-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTGHB955 route product structure diagram
    ACTGHB95555040-43-2
Inquiry

3. ACTGHB955 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTGHB955 route product structure diagram
    ACTGHB95555040-43-2
Inquiry

Comments (0)